The Centre for Commercialization of Regenerative Medicine (CCRM) is a Centre of Excellence for Commercialization of Research established in 2012. Its goal is to translate promising discoveries into commercially viable regenerative medicine products to accelerate the growth of the industry. It has formed an industry consortium of Canadian and international companies and has established three technical platforms to support stem cell science translation. CCRM also provides business support to its industry partners, conducts technology evaluation, helps bundle intellectual property into marketable products and engages venture capital sources.